Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
In this randomized multicentric phase II study, patients with colorectal carcinoma with
resectable hepatic metastasis will be randomized to treatment with dendritic cells or to
observation, following conventional treatment with surgery and chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Clinica Universidad de Navarra, Universidad de Navarra